Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Anthera Pharmaceuticals Inc

+ Add to Watchlist

ANTH:US

2.4500 USD 0.1000 3.92%

As of 14:32:14 ET on 01/30/2015.

Snapshot for Anthera Pharmaceuticals Inc (ANTH)

Open: 2.5600 Day's Range: 2.4000 - 2.5700 Volume: 139,583
Previous Close: 2.5500 52wk Range: 1.4600 - 3.7900 1-Yr Rtn: -16.38%

Stock Chart for ANTH

No chart data available.
  • ANTH:US 2.4500
  • 1D
  • 1M
  • 1Y
2.5500
Interactive ANTH Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ANTH

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.5200
Est. EPS (USD) (12/2014) -1.3000
Est. PEG Ratio -
Market Cap (M USD) 56.20
Shares Outstanding (M) 22.94
30 Day Average Volume 606,635
Price/Book (mrq) 12.5856
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/12/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ANTH

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ANTH

Anthera Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing anti-inflammatory therapeutics for cardiovascular diseases, lupus and other serious diseases.

Paul F TruexPresident/CEO/FounderDebra OdinkSenior VP/CTO
Colin HislopSenior VP/Chief Medical OfcrKlara A Dickinson-EasonSenior VP/Chief Regulatory Ofcr
More Company Profile & Key Executives for ANTH

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil